A bipartisan group of U.S. senators, including Maine Sen. Angus King, and New Hampshire Sens. Jeanne Shahaeen and Kelly Ayotte, is calling for an investigation into the Food and Drug Administration’s recent decision to approve the use of the painkiller OxyContin by children as young as 11 years old.

They also asked in the letter to the Senate Health, Education, Labor and Pensions Committee on Wednesday for an investigation into the rise in opioid abuse and overdose deaths.

They said the August decision to approve the use of OxyContin in pediatric patients is a step in the wrong direction and could lead to a rise in use among a population that is already at a higher risk for developing dependency and addiction.


Only subscribers are eligible to post comments. Please subscribe or to participate in the conversation. Here’s why.

Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.